DCT

2:05-cv-00421

Aventis Pharma Deutschland GmbH v. Lupin Ltd

General

Filed

07/19/05

Cause of ActionInfringement

SectorBiotech

Status

Closed (01/30/09)

Patent Owner

Operating Company (L)

PACER2:05-cv-00421

Appeals06-1530

CourtE.D. Virginia

Judge	Period	PO Win Rate
Robert G. Doumar	--	88%

Plaintiff

Party

Name	Ratings
Aventis Pharma Deutschland GmbH	L4E
King Pharmaceuticals Inc	L5E

Attorney

Name	Ratings
Jones Day	L5A
Gregory A. Castanias	L5E
Jonathan A. Muenkel	L4D
F. Dominic Cerrito	L3B
Daniel L. Malone	L3E
Sheila L. Shadmand	---- --
Kaye Scholer LLP	L4C
Benjamin Hsing	L5B
Sapna W. Palla	L3C
Joel Katcoff	L3E
Steven J. Glassman	L1-- --
Catherine Youssef	---- --
Douglas A. Tucker	---- --
Leclair Ryan	L1E
Dana J. Finberg	L5B
Alan D. Albert	L4E
Ray W. King	---- --
Christopher D. Lagow	---- --

Defendant

Party

Name	Ratings
Lupin Ltd	L5E
Lupin Pharmaceuticals Inc	L5E

Attorney

Name	Ratings
Willcox & SavageLocal	L2A
Conrad M. Shumadine	L2A
Rakoczy Molino Mazzochi Siwik LLP	L1E
Adam G. Kelly	L5D
Alice L. Riechers	L5E
Paul J. Molino	L4A
Deanne M. Mazzochi	L4B
William A. Rakoczy	L4E